Buparvaquone is a hydroxynaphthoquinone antiprotozoal related to atovaquone, used in veterinary medicine for the treatment of East Coast Fever (Theileria parva infection) in cattle. Simson Pharma's Buparvaquone reference standard supports QC for this important livestock-disease antiprotozoal.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Buparvaquone Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.